GlassScriptPhysician profile
Kenneth Wong
NPI 1073775433
$1,100.75
in general payments reported to CMS, 2019-2025
12 companies · $384 in 2025
The $384 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.39 · 2021: $135 · 2022: $126 · 2023: $280 · 2024: $130 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $280.89 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $228.94 | 2021-2025 | Nucala |
| Genzyme Corporation | $209.10 | 2021-2025 | |
| Abbott Laboratories | $112.01 | 2025 | Esprit |
| Optinose US, INC. | $96.61 | 2019-2025 | |
| Aerin Medical INC. | $57.30 | 2019-2024 | |
| Hologic Sales and Service, LLC | $28.22 | 2025 | Coolseal Generator |
| Smith+Nephew, INC. | $23.66 | 2021 | |
| Boston Scientific Corporation | $17.18 | 2019 | |
| Pfizer INC. | $17.14 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.73 | 2021 | |
| Merck Sharp & Dohme LLC | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.